Language

English

Publication Date

11-13-2025

Journal

Journal of Medicinal Chemistry

DOI

10.1021/acs.jmedchem.5c00773

PMID

41134612

PMCID

PMC12681228

PubMedCentral® Posted Date

12-7-2025

PubMedCentral® Full Text Version

Author MSS

Abstract

Pharmacological degradation of receptor-interacting protein kinase 1 (RIPK1) offers a compelling therapeutic strategy to overcome its scaffolding role in tumor resistance and to enhance the efficacy of immune checkpoint blockade (ICB) therapies. In this study, we report the discovery of a novel RIPK1 degrader, LD5097(24b), developed through systematic optimization of its precursor compound, LD4172—specifically refining the linker, RIPK1 warhead exit vector, and VHL ligand components. LD5097(24b) exhibits potent and selective RIPK1 degradation, triggering rapid and efficient downregulation of RIPK1 and significantly enhancing TNFα-mediated apoptosis in Jurkat cells. Compared to LD4172, LD5097(24b) demonstrates markedly improved metabolic stability and pharmacokinetic properties. In vivo, a single dose of LD5097(24b) induced over 70% RIPK1 degradation in Jurkat xenograft tumors in mice within 6 hours. These results position LD5097(24b) as a promising therapeutic candidate, combining potent biological activity with favorable drug-like properties, and offering strong potential for application in cancer immunotherapy.

Keywords

Humans, Receptor-Interacting Protein Serine-Threonine Kinases, Animals, Jurkat Cells, Mice, Drug Design, Apoptosis, Antineoplastic Agents, Xenograft Model Antitumor Assays, Structure-Activity Relationship, Proteolysis, RIPK1; PROTAC; linker; optimization; PK, PD

Published Open-Access

yes

Download

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.